Case study of Guillain-Barré syndrome with acute flaccid paralysis

Authors

  • Vankodoth Sireesha CMR College of pharmacy, Hyderabad, Telangana, India
  • Laxmi Sahithya CMR College of pharmacy, Hyderabad, Telangana, India
  • Vaishali Akshitha CMR College of pharmacy, Hyderabad, Telangana, India
  • Rama Rao Tadikonda CMR College of pharmacy, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20232888

Keywords:

GBS, Intravenous immunoglobulin therapy, Acute flaccid paralysis

Abstract

Guillain-Barre syndrome (GBS) is a sudden and a complicated degenerative neurological disorder which can be acute or chronic in nature. Etiology remains unclear, but pathophysiology shows demyelination of spinal nerve roots characterised by symmetrical limb weakness and muscle stiffness. Death is rare. Early diagnosis and prompt treatment should occur in severe cases. Here we discuss a rare case of GBS as paraesthesia and acute flaccid paralysis. This case report focuses on a 9-year-old male patient presenting with c/o progressive muscle weakness and paraesthesia in the lower extremities. The clinical examination revealed bilateral lower limb weakness, absent deep tendon reflexes, and diminished vibration sense, acute flaccid paralysis. Diagnostic evaluations of CT scan of brain and spine and other preliminary tests confirmed the diagnosis of GBS by demonstrating characteristic findings of demyelinating polyneuropathy and elevated protein levels without pleocytosis, respectively. Prompt initiation of intravenous immunoglobulin therapy and supportive measures, such as physical therapy, were implemented. Over a four-week period, the patient showed progressive improvement in muscle strength, starting from the slight movement in fingers and toes. This case report underscores the importance of accurate diagnosis, and timely initiation of appropriate treatment strategies in managing GBS, highlighting the efficacy of intravenous immunoglobulin therapy as a first-line intervention for GBS patients.

Metrics

Metrics Loading ...

References

R1. Willison HJ, Jacobs BC, Van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-27.

Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366(24):2294-304.

Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. The lancet. 2021;397(10280):1214-28.

Dash S, Pai AR, Kamath U, Rao P. Pathophysiology and diagnosis of Guillain-Barré syndrome-challenges and needs. Int J Neurosci. 2015;125(4):235-40.

Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014;9(9):CD002063.

Eonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nature Rev Neurol. 2019;15(11):671-83.

Raphaël JC, Chevret S, Hughes RA, Djillali A. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012;7(7):CD001798.

Van den Berg B, Walgaard C, Drenthen J, Christiaan F, Bart CJ, Pieter AD. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment, and prognosis. Nat Rev Neurol. 2014;10(8):469-82.

Jing S, Yu G, Qingyang C, Zhijie N, Guangxian N. Affiliations expand. Case report: early onset GBS mimicking stroke. Front Neurol. 2021;12:525699.

Levison LS, Thomsen RW, Markvardsen LK, Christensen DH, Sindrup SH, Andersen H. Pediatric Guillain-Barré syndrome in a 30-year nationwide cohort. Pediatric neurology. 2020;107:57-63.

Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain‐Barré syndrome. Cochrane Database Systematic Rev. 2013(10).

Downloads

Published

2023-09-27

How to Cite

Sireesha, V., Sahithya, L., Akshitha, V., & Tadikonda, R. R. (2023). Case study of Guillain-Barré syndrome with acute flaccid paralysis. International Journal of Contemporary Pediatrics, 10(10), 1584–1586. https://doi.org/10.18203/2349-3291.ijcp20232888

Issue

Section

Case Reports